VTRS Stock Overview
Viatris Inc. operates as a healthcare company worldwide.
Viatris Inc. Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$11.14|
|52 Week High||US$15.60|
|52 Week Low||US$8.42|
|1 Month Change||11.74%|
|3 Month Change||12.75%|
|1 Year Change||-12.63%|
|3 Year Change||-40.68%|
|5 Year Change||-70.78%|
|Change since IPO||216.61%|
Recent News & Updates
|VTRS||US Pharmaceuticals||US Market|
Return vs Industry: VTRS underperformed the US Pharmaceuticals industry which returned 9.9% over the past year.
Return vs Market: VTRS exceeded the US Market which returned -18.5% over the past year.
|VTRS Average Weekly Movement||6.2%|
|Pharmaceuticals Industry Average Movement||11.0%|
|Market Average Movement||7.4%|
|10% most volatile stocks in US Market||15.5%|
|10% least volatile stocks in US Market||3.3%|
Stable Share Price: VTRS is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: VTRS's weekly volatility (6%) has been stable over the past year.
About the Company
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs).
Viatris Inc. Fundamentals Summary
|VTRS fundamental statistics|
Is VTRS overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|VTRS income statement (TTM)|
|Cost of Revenue||US$9.42b|
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
|Earnings per share (EPS)||0.66|
|Net Profit Margin||4.80%|
How did VTRS perform over the long term?See historical performance and comparison